Données cliniques probantes

Sources et références

Chaque outil d’évaluation et chaque allégation clinique sur HiBoop est étayé par des recherches évaluées par les pairs. Ce sont les études fondamentales qui valident les outils que nous mettons en œuvre.

Voir l'aperçu de la science clinique sur HiQō

Troubles dépressifs

DASS-21: Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335-343. PMID: 7726811DOI: 10.1016/0005-7967(94)00075-u

PHQ-8: Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114(1-3):163-173. PMID: 18752852DOI: 10.1016/j.jad.2008.06.026

QIDS-SR: Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583. PMID: 12946886DOI: 10.1016/s0006-3223(02)01866-8

PHQ-9: Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. PMID: 11556941DOI: 10.1046/j.1525-1497.2001.016009606.x

PHQ-2: Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284-1292. PMID: 14583691DOI: 10.1097/01.MLR.0000093487.78664.3C

PHQ-15: Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64(2):258-266. PMID: 11914441DOI: 10.1097/00006842-200203000-00008

PHQ-A: Johnson JG, Harris ES, Spitzer RL, Williams JB. The patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients. J Adolesc Health. 2002;30(3):196-204. PMID: 11869927DOI: 10.1016/s1054-139x(01)00333-0

HAM-D: Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62. PMID: 14399272DOI: 10.1136/jnnp.23.1.56

MADRS: Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389. PMID: 444788DOI: 10.1192/bjp.134.4.382

Anxiété

SCARED: Birmaher B, Khetarpal S, Brent D, Cully M, Balach L, Kaufman J, Neer SM. The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry. 1997;36(4):545-553. PMID: 9100430DOI: 10.1097/00004583-199704000-00018

SCARED-P: Birmaher B, Khetarpal S, Brent D, Cully M, Balach L, Kaufman J, Neer SM. The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry. 1997;36(4):545-553. PMID: 9100430DOI: 10.1097/00004583-199704000-00018

GAD-7: Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097. PMID: 16717171DOI: 10.1001/archinte.166.10.1092

GAD-2: Kroenke K, Spitzer RL, Williams JBW, et al. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Ann Intern Med. 2007;146(5):317-325. PMID: 17339617DOI: 10.7326/0003-4819-146-5-200703060-00004

LSAS: Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141-173. PMID: 2885745DOI: 10.1159/000414022

SPIN: Connor KM, Davidson JR, Churchill LE, et al. Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale. Br J Psychiatry. 2000;176:379-386. PMID: 10827888DOI: 10.1192/bjp.176.4.379

Bipolaire

MDQ: Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157(11):1873-1875. PMID: 11058490DOI: 10.1176/appi.ajp.157.11.1873

ASRM: Altman EG, Hedeker D, Peterson JL, Davis JM. The Altman Self-Rating Mania Scale. Biol Psychiatry. 1997;42(10):948-959. PMID: 9359982DOI: 10.1016/S0006-3223(96)00548-3

Traumatisme et TSPT

PC-PTSD-5: Prins A, Bovin MJ, Smolenski DJ, Marx BP, Kimerling R, Jenkins-Guarnieri MA, Kaloupek DG, Schnurr PP, Kaiser AP, Leyva YE, Tiet QQ. The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): development and evaluation within a veteran primary care sample. J Gen Intern Med. 2016;31(10):1206-1211. PMID: 27170304DOI: 10.1007/s11606-016-3703-5

PCL-5: Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and initial psychometric evaluation. J Trauma Stress. 2013;26(4):419-425. PMID: 23934939DOI: 10.1002/jts.21830

ITQ: Cloitre M, Hyland P, Bisson JI, Brewin CR, Roberts NP, Maercker A, et al. The International Trauma Questionnaire: Development of a self-report measure of ICD-11 PTSD and complex PTSD. Acta Psychiatr Scand. 2018;138(6):536-546. PMID: 30178492DOI: 10.1111/acps.12956

ACES: Felitti VJ, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: The Adverse Childhood Experiences (ACE) Study. Am J Prev Med. 1998;14(4):245-258. PMID: 9635069DOI: 10.1016/s0749-3797(98)00017-8

LEC-5: Weathers FW, Blake DD, Schnurr PP, Kaloupek DG, Marx BP, Keane TM. Manuel diagnostique et statistique des troubles mentaux (DSM-5). 2013.

Troubles obsessionnels-compulsifs et connexes

C-FOCI: Storch EA, Khanna M, Merlo LJ, Loew BA, Franklin M, Reid JM, Goodman WK, Murphy TK. Children's Florida Obsessive Compulsive Inventory: psychometric properties and feasibility of a self-report measure of obsessive-compulsive symptoms in youth. Child Psychiatry Hum Dev. 2009;40(3):467-483. PMID: 19326209DOI: 10.1007/s10578-009-0138-9

DOCS: Abramowitz JS, Deacon BJ, Olatunji BO, Wheaton MG, Berman NC, Losardo D, Timpano KR, McGrath PB, Riemann BC, Adams T, Björgvinsson T, Storch EA, Hale LR. Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the Dimensional Obsessive-Compulsive Scale. Psychol Assess. 2010;22(1):180-198. PMID: 20230164DOI: 10.1037/a0018260

FOCI: Storch EA, Kaufman DAS, Bagner D, Merlo LJ, Shapira NA, Geffken GR, Murphy TK, Goodman WK. Florida Obsessive-Compulsive Inventory: development, reliability, and validity. J Clin Psychol. 2007;63(9):851-859. PMID: 17674398DOI: 10.1002/jclp.20382

Y-BOCS: Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale I: development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006-1011. PMID: 2684084DOI: 10.1001/archpsyc.1989.01810110048007

OCI-R: Foa EB, Huppert JD, Leiberg S, et al. The Obsessive-Compulsive Inventory: development and validation of a short version. Psychol Assess. 2002;14(4):485-496. PMID: 12501574DOI: 10.1037/1040-3590.14.4.485

Troubles liés à une substance et troubles addictifs

ARC: Groshkova T, Best D, White W. The Assessment of Recovery Capital: properties and psychometrics of a measure of addiction recovery strengths. Drug Alcohol Rev. 2013;32(2):187-194. PMID: 22882622DOI: 10.1111/j.1465-3362.2012.00489.x

BARC-10: Vilsaint CL, Kelly JF, Bergman BG, Groshkova T, Best D, White W. Development and validation of a Brief Assessment of Recovery Capital (BARC-10) for alcohol and drug use disorder. Drug Alcohol Depend. 2017;177:71-76. PMID: 28578224DOI: 10.1016/j.drugalcdep.2017.03.022

CRAFFT: Knight JR, Sherritt L, Shrier LA, Harris SK, Chang G. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med. 2002;156(6):607-614. PMID: 12038895DOI: 10.1001/archpedi.156.6.607

EDS: Morean ME, Krishnan-Sarin S, Sussman S, Foulds J, Fishbein H, Grana R, O'Malley SS. Psychometric evaluation of the E-cigarette Dependence Scale. Nicotine Tob Res. 2019;21(11):1556-1564. PMID: 29301008DOI: 10.1093/ntr/ntx271

SOGS: Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry. 1987;144(9):1184-1188. PMID: 3631315DOI: 10.1176/ajp.144.9.1184

TAPS: McNeely J, Wu LT, Subramaniam G, et al. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Ann Intern Med. 2016;165(10):690-699. PMID: 27595276DOI: 10.7326/M16-0317

AUDIT: Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption. Addiction. 1993;88(6):791-804. PMID: 8329970DOI: 10.1111/j.1360-0443.1993.tb02093.x

CAGE: Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984;252(14):1905-1907. PMID: 6471323DOI: 10.1001/jama.252.14.1905

MAST: Selzer ML. The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument. Am J Psychiatry. 1971;127(12):1653-1658. PMID: 5565851DOI: 10.1176/ajp.127.12.1653

DAST-10: Skinner HA. The drug abuse screening test. Addict Behav. 1982;7(4):363-371. PMID: 7183189DOI: 10.1016/0306-4603(82)90005-3

ASSIST-3: Humeniuk R, Ali R, Babor TF, et al. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2008;103(6):1039-1047. Addiction. 2008;103(6):1039-1047. PMID: 18373724DOI: 10.1111/j.1360-0443.2007.02114.x

BBGS: Gebauer L, LaBrie RA, Shaffer HJ. Optimizing DSM-IV classification accuracy: A brief bio-social screen for gambling disorders among the general household population. Can J Psychiatry. 2010;55(2):82-90. PMID: 20181303DOI: 10.1177/070674371005500204

SCOFF: Morgan JF, Reid F, Lacey JH. The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ. 1999;319(7223):1467-1468. PMID: 10582927DOI: 10.1136/bmj.319.7223.1467

IGDS9-SF: Pontes HM, Griffiths MD. Measuring DSM-5 Internet Gaming Disorder: Development and validation of a short psychometric scale. Comput Human Behav. 2015;45:137-143. DOI: 10.1016/j.chb.2014.12.006

ORT: Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432-442. PMID: 16336480DOI: 10.1111/j.1526-4637.2005.00072.x

Troubles neurodéveloppementaux

AQ-10: Allison C, Auyeung B, Baron-Cohen S. Toward brief "Red Flags" for autism screening: the Short Autism Spectrum Quotient and the Short Quantitative Checklist for Autism in toddlers in 1,000 cases and 3,000 controls. J Am Acad Child Adolesc Psychiatry. 2012;51(2):202-212.e7. PMID: 22265366DOI: 10.1016/j.jaac.2011.11.003

CAST: Scott FJ, Baron-Cohen S, Bolton P, Brayne C. The CAST (Childhood Asperger Syndrome Test): preliminary development of a UK screen for mainstream primary-school-age children. Autism. 2002;6(1):9-31. PMID: 11918111DOI: 10.1177/1362361302006001003

CAT-Q: Hull L, Mandy W, Lai MC, Baron-Cohen S, Allison C, Smith P, Petrides KV. Development and Validation of the Camouflaging Autistic Traits Questionnaire (CAT-Q). J Autism Dev Disord. 2019;49(3):819-833. PMID: 30361940DOI: 10.1007/s10803-018-3792-6

EQ: Baron-Cohen S, Wheelwright S. The empathy quotient: an investigation of adults with Asperger syndrome, and normal sex differences. J Autism Dev Disord. 2004;34(2):163-175. PMID: 15162935DOI: 10.1023/b:jadd.0000022607.19833.00

EQ-10: Baron-Cohen S, Wheelwright S. The empathy quotient: an investigation of adults with Asperger syndrome, and normal sex differences. J Autism Dev Disord. 2004;34(2):163-175. PMID: 15162935DOI: 10.1023/b:jadd.0000022607.19833.00

ASRS: Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-256. PMID: 15841682DOI: 10.1017/s0033291704002892

RAADS-R: Ritvo RA, Ritvo ER, Guthrie D, et al. The Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R): a scale to assist the diagnosis of Autism Spectrum Disorder in adults. J Autism Dev Disord. 2011;41(8):1076-1089. PMID: 21086033DOI: 10.1007/s10803-010-1133-5

AQ: Baron-Cohen S, et al. The Autism-Spectrum Quotient (AQ): Evidence from Asperger Syndrome/Autism Spectrum Disorder, Males and Females, Scientists and Mathematicians. J Autism Dev Disord. 2001;31(1):5-17. PMID: 11439754DOI: 10.1023/A:1005653411471

SWAN: van der Elst W, et al. The Strengths and Weaknesses of ADHD symptoms and Normal behavior scale (SWAN). J Child Psychol Psychiatry. 2007;48(11):1080-1087. PMID: 17995483DOI: 10.1111/j.1469-7610.2007.01783.x

VADRS: Wolraich ML, et al. Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population. J Pediatr Psychol. 2003;28(8):559-567. PMID: 14602846DOI: 10.1093/jpepsy/jsg046

ACOS-SELF: Adamis D, et al. Measuring clinical outcomes in adult ADHD clinics: psychometrics of a new scale, the adult ADHD Clinical Outcome Scale. BJPsych Open. 2024;10(6):e180. PMID: 39397668DOI: 10.1192/bjo.2024.739

WURS-25: Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150(6):885-890. PMID: 8494063DOI: 10.1176/ajp.150.6.885

WURS-61: Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150(6):885-890. PMID: 8494063DOI: 10.1176/ajp.150.6.885

BAARS-IV: Barkley RA. Psychometric properties of the Barkley Adult ADHD Rating Scale-IV (BAARS-IV) in a large community sample. J Atten Disord. 2012;16(6):460-471. PMID: 22166469DOI: 10.1177/1087054711430331

ESQ-R: Strait JE, et al. Refinement and Psychometric Evaluation of the Executive Skills Questionnaire-Revised. Contemp Sch Psychol. 2020;24(4):378-388. DOI: 10.1007/s40688-018-00224-x

Troubles dissociatifs

MID: Dell PF. The multidimensional inventory of dissociation (MID): A comprehensive measure of pathological dissociation. J Trauma Dissociation. 2006;7(2):77-106. PMID: 16769667DOI: 10.1300/J229v07n02_06

DES-B: Dalenberg CJ, Carlson EB. Brief Dissociative Experiences Scale (DES-B). Manuel diagnostique et statistique des troubles mentaux (DSM-5). 2013.

Déficience fonctionnelle

DARS: Mackrain M. Devereux Adult Resilience Survey (DARS). Devereux Center for Resilient Children. 2013.

GAS: Kiresuk TJ, Sherman RE. Goal attainment scaling: a general method for evaluating comprehensive community mental health programs. Community Ment Health J. 1968;4(6):443-453. PMID: 24185570DOI: 10.1007/BF01530764

RTW-SE: Lagerveld SE, Blonk RWB, Brenninkmeijer V, Wijngaards-de Meij L, Schaufeli WB. Work-focused treatment of common mental disorders and return to work: a criterion groups validation study. J Occup Rehabil. 2010;20(2).

SWLS: Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985;49(1):71-75. PMID: 16367493DOI: 10.1207/s15327752jpa4901_13

WSAS: Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180(5):461-464. PMID: 11983645DOI: 10.1192/bjp.180.5.461

IADL: Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179-186. PMID: 5349366DOI: 10.1093/geront/9.3_Part_1.179

WFIRS-S: Canu WH, et al. Psychometric Properties of the Weiss Functional Impairment Rating Scale: Evidence for Utility in Research, Assessment, and Treatment of ADHD in Emerging Adults. J Atten Disord. 2020;24(12):1648-1660. PMID: 27481918DOI: 10.1177/1087054716661421

IQCODE-SR: Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med. 1994;24(1):145-153. PMID: 8208879DOI: 10.1017/s003329170002691x

WHOQOL-BREF: The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551-558. PMID: 9626712DOI: 10.1017/s0033291798006667

Suicide et risque

SIDAS: van Spijker BAJ, et al. The Suicidal Ideation Attributes Scale (SIDAS): Community-based validation study of a new scale for the measurement of suicidal ideation. Suicide Life Threat Behav. 2014;44(4):408-419. PMID: 24612048DOI: 10.1111/sltb.12084

C-SSRS: Posner K, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266-1277. PMID: 22193671DOI: 10.1176/appi.ajp.2011.10111704

Douleur et risque d'opioïdes

PMQ: Adams LL, et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage. 2004;27(5):440-459. PMID: 15120773DOI: 10.1016/j.jpainsymman.2003.10.009

PSS: Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385-396. PMID: 6668417DOI: 10.2307/2136404

RPQ: King NS, et al. The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J Neurol. 1995;242(9):587-592. PMID: 8551320DOI: 10.1007/BF00868811

Troubles du sommeil

ISI: Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601-608. PMID: 21532953DOI: 10.1093/sleep/34.5.601

PSQI: Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193-213. PMID: 2748771DOI: 10.1016/0165-1781(89)90047-4

Cognitif

MoCA: Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699. PMID: 15817019DOI: 10.1111/j.1532-5415.2005.53221.x

MMSE: Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198. PMID: 1202204DOI: 10.1016/0022-3956(75)90026-6

Psychose et TMG

PANSS: Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276. PMID: 3616518DOI: 10.1093/schbul/13.2.261

WHODAS 2.0: Üstün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010;87(10):753-759. PMID: 21076562DOI: 10.2471/BLT.09.067231

Personnalité

ZAN-BPD: Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Pers Disord. 2003;17(3):233-242. PMID: 12839102DOI: 10.1521/pedi.17.3.233.22147

CAQ: Krug SE. Clinical Analysis Questionnaire (CAQ) Manual. Institute for Personality and Ability Testing (IPAT). 1980.

NPI-16: Ames DR, Rose P, Anderson CP. The NPI-16 as a short measure of narcissism. J Res Pers. 2006;40(4):440-450. DOI: 10.1016/j.jrp.2005.03.002

DERS: Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the Difficulties in Emotion Regulation Scale. J Psychopathol Behav Assess. 2004;26(1):41-54. DOI: 10.1023/B:JOBA.0000007455.08539.94

Psychothérapies

CBT: Hofmann SG, Asnaani A, Vonk IJJ, Sawyer AT, Fang A. The Efficacy of Cognitive Behavioural Therapy: A Review of Meta-analyses. Cognit Ther Res. 2012;36(5):427-440. PMID: 23459093DOI: 10.1007/s10608-012-9476-1

DBT: Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL. Cognitive-behavioural treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry. 1991;48(12):1060-1064. PMID: 1845222DOI: 10.1001/archpsyc.1991.01810360024003

Données probantes sur les SAM

Diagnostic Delay: Wang PS, et al. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):603-613. Arch Gen Psychiatry. 2005;62(6):603-613. PMID: 15939838DOI: 10.1001/archpsyc.62.6.603

Zhu M, et al. The Efficacy of Measurement-Based Care for Depressive Disorders: Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Psychiatry. 2021;82(5):21r14034. J Clin Psychiatry. 2021;82(5):21r14034. PMID: 34587377DOI: 10.4088/JCP.21r14034

Lambert MJ, Whipple JL, Kleinstauber M. Collecting and delivering progress feedback: A meta-analysis of routine outcome monitoring. Psychotherapy (Chic). 2018;55(4):520-537. PMID: 30335463DOI: 10.1037/pst0000167

Scott K, Lewis CC. Using Measurement-Based Care to Enhance Any Treatment. Cogn Behav Pract. 2015;22(1):49-59. PMID: 27330267DOI: 10.1016/j.cbpra.2014.01.010

Admission et antécédents cliniques

Attachment History Checklist: Hazan C, Shaver PR. Romantic love conceptualized as an attachment process. J Pers Soc Psychol. 1987;52(3):511-524. PMID: 3572722DOI: 10.1037/0022-3514.52.3.511

Confidential Client Questionnaire: Leeds AM. A Guide to the Standard EMDR Therapy Protocols for Clinicians, Supervisors, and Consultants. Springer Publishing Company. 2016.

Fondements théoriques

Marshall McLuhan: L'affirmation selon laquelle « notre ère d'anxiété est causée par la technologie d'hier » est une interprétation populaire d'une célèbre citation du théoricien canadien des médias Marshall McLuhan, qui a noté : « Notre ère d'anxiété est, en grande partie, le résultat de la tentative de faire le travail d'aujourd'hui avec les outils et les concepts d'hier » Pour comprendre les médias : Les prolongements de l'homme 1964.

Suivi systématique des résultats et alliance

ORS: Miller SD, Duncan BL, Brown J, Sparks JA, Claud DA. The outcome rating scale: A preliminary study of the reliability, validity, and feasibility of a brief visual analog measure. J Brief Therapy. 2003;;2(2):91–100.

SRS: Duncan BL, Miller SD, Sparks JA, Claud DA, Reynolds LR, Brown J, Johnson LD. The session rating scale: Preliminary psychometric properties of a 'working' alliance measure. J Brief Therapy. 2003;;2(1):3–12.

WAI: Horvath AO, Greenberg LS. Development and validation of the Working Alliance Inventory. J Couns Psychol. 1989;;36(2):223–233.

WAI Alliance Meta-analysis: Flückiger C, Del Re AC, Wampold BE, Horvath AO. The alliance in adult psychotherapy: A meta-analytic synthesis. Psychotherapy. 2018;;55(4):316–340. PMID: 29792475

Alliance Review 2023: Wampold BE, Flückiger C. The alliance in mental health care: conceptualization, evidence and clinical applications. World Psychiatry. 2023;22(1):25–41. PMID: 36640398DOI: 10.1002/wps.21035

MSPSS: Zimet GD, Dahlem NW, Zimet SG, Farley GK. The Multidimensional Scale of Perceived Social Support. J Pers Assess. 1988;;52(1):30–41.

MSPSS Psychometrics: Zimet GD, Powell SS, Farley GK, Werkman S, Berkoff KA. Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. J Pers Assess. 1990;;55(3–4):610–617. PMID: 2280326

Cadres de diagnostic

CGI: Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept of Health, Education, and Welfare. 1976.

DSM-5 Level 1 Cross-Cutting: Narrow WE, Clarke DE, Kuramoto SJ, Kraemer HC, Kupfer DJ, Greiner L, Regier DA. DSM-5 field trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5. Am J Psychiatry. 2013;170(1):71-82. PMID: 23111499DOI: 10.1176/appi.ajp.2012.12071000

DSM-5-TR: Manuel diagnostique et statistique des troubles mentaux, cinquième édition, révision du texte (DSM-5-TR). American Psychiatric Association. 2022.

ICD-11: Classification internationale des maladies pour les statistiques de mortalité et de morbidité (11e révision). Organisation mondiale de la Santé. 2018.

mhGAP: Guide d'intervention mhGAP pour les troubles mentaux, neurologiques et liés à l'utilisation de substances dans les établissements de santé non spécialisés, version 2.0. Organisation mondiale de la Santé (2016). Organisation mondiale de la Santé. 2016.

NICE Guidelines: Lignes directrices sur la santé mentale du NICE National Institute for Health and Care Excellence (NICE). 2024.

Research Domain Criteria (RDoC): NIMH Research Domain Criteria (RDoC) National Institute of Mental Health (NIMH). 2024.

Clinical Assessment Frameworks: Lignes directrices sur la santé mentale et la consommation de substances Health Canada / Santé Canada. 2023.

Mental Health Surveillance: Cadres de surveillance et de prévention en santé mentale Centers for Disease Control and Prevention (CDC). 2024.

Toutes les références sont dérivées de lignes directrices institutionnelles, de normes de pratique clinique et de recherches évaluées par des pairs indexées via PubMed , l'Organisation mondiale de la Santé (OMS) et les dépôts de santé gouvernementaux. Pour demander une documentation clinique ou des citations supplémentaires, contactez-nous.